bluuebunny/crossref_metadata_2025_split huggingface dataset:
Individual Reproductive Success of Largemouth Bass and Smallmouth Bass Subjected to Different Components of Competitive Angling Events
Authors: Siepker Michael J. , Cooke Steven J. , Wahl David H. , Philipp David P. 
Published: May 2009

AbstractThe continued popularity of angling for largemouth bass Micropterus salmoides and smallmouth bass M. dolomieu has led to concerns about the effects it may have on fish populations, including the realized fitness of individuals. Although catch‐and‐release angling and its effects on nest abandonment have been well documented, very little research has examined the effect that competitive angling practices may have on nest abandonment. We subjected nest‐guarding male largemouth bass in one lake and smallmouth bass in four lakes to various competitive angling practices (i.e., livewell retention, release after displacement from the nest, and a combination of these practices) and assessed subsequent nest abandonment. We also examined the importance of nest predation on the nest abandonment decisions of male bass by protecting some of the nests from predation after the angling event. Nest abandonment by largemouth bass was affected by angling treatment, the water depth at the nest site, and brood size but was not affected by male size. Angling treatment and lake influenced abandonment by smallmouth bass guarding eggs, whereas angling treatment, lake, and the presence of a protective nest cover influenced nest abandonment by smallmouth bass guarding fry. The only factor that influenced abandonment for both species and all stages was angling treatment, with abandonment being highest for all treatments that involved prolonged removal and displacement (i.e., the complete tournament simulation). These findings could be important to bass populations if year‐class size is related to the number of successful nests. The effects of angling, both catch and release and competitive, on individual nesting success in largemouth bass and smallmouth bass are now well understood, although additional work is needed to determine whether disruption of nesting at the individual level translates to population‐level effects.
Mislabeling of Two Commercial North American Hake Species Suggests Underreported Exploitation of Offshore Hake
Authors: Garcia‐Vazquez Eva , Horreo Jose L. , Campo Daniel , Machado‐Schiaffino Gonzalo , Bista Iliana , Triantafyllidis Alexandros , Juanes Francis 
Published: May 2009

AbstractMislabeling of North American merlucciid hakes in stock surveys and commercial market samples was detected by employing nuclear 5S ribosomal DNA (rDNA) and mitochondrial cytochrome b variation as molecular markers. Results showed that offshore hake Merluccius albidus is sold in European markets but is labeled as the morphologically similar silver hake M. bilinearis, which is the target species of the fishery. This suggests that offshore hake may be inadvertently included within silver hake landings, as the two species overlap in the southern area of silver hake distribution (approximately 41°‐35°N latitude near North American coasts). An inexpensive and technically easy technique based on polymerase chain reaction (PCR) amplification of a fragment of 5S rDNA and visualization of PCR products in agarose gels is recommended for routine species assignation in landings for purposes of exploitation estimates and for authentication of commercial hake species.
Blood Flow Distribution of Repaired Lip in Cleft Lip Patients
Authors: Kondo Yuko , Takahashi Takumi , Oba Yasuo , Kuroda Shingo , Tanaka Eiji , Moriyama Keiji 
Published: May 2009

Abstract
Objective: To investigate the blood flow distribution in the repaired lip of cleft patients using a laser Doppler imager and to evaluate the difference in blood flow of the scar tissue between unilateral cleft lip patients with and without cleft palate.
Materials and Methods: Twenty patients with either unilateral cleft lip only (CL group, n = 8) or cleft lip and palate (CLP group, n = 12) were used as subjects. The blood flow of the upper lip was two-dimensionally visualized by a color scale alongside the corresponding photo image of the tissue surface with laser Doppler imaging. The upper lip photo image was divided into five regions: scar, white lip on the cleft side, white lip on the noncleft side, red lip on the cleft side, and red lip on the noncleft side. The average flux score (AFS), which is proportional to blood flow, was analyzed in each region.
Results: The AFS for the scar region was significantly (P &lt; .05) lower than in the other four regions. The AFS for the red lip on the cleft side was not significantly different from that for the noncleft side. The white lip revealed a significantly (P &lt; .05) higher score on the cleft side than on the noncleft side. The AFS ratio (AFS in the scar region/AFS in the white lip region) was significantly (P &lt; .01) lower in the CLP group than in the CL group.
Conclusions: These results suggest that blood flow distribution in the repaired lip might be affected by the anatomic features of the cleft.
Pain and Orthodontic Treatment
Authors: Krukemeyer Amy M. , Arruda Airton O. , Inglehart Marita Rohr 
Published: May 2009

Abstract
Objective: To explore whether patients' pain experiences and orthodontists' assessments of their patients' pain levels are consistent and whether orthodontists are aware of their patients' use of pain medication.
Materials and Methods: Survey data were collected from 116 adolescent patients (44 male, 72 female; aged 10 to 19 years; mean age, 14.27 years) and from their orthodontic care providers.
Results: While only 18.0% of these patients agreed that they had pain during their last orthodontic appointment, 58.5% indicated that they experienced pain for a few days after their appointment. On average, dentists underestimated the patients' pain during the last appointment (rated on a 5-point scale, with 1 indicating no pain: providers = 2.01 vs patients = 2.28; P = .042), immediately after the last appointment (1.93 vs 2.34; P = .005), and 1 day (1.77 vs 2.53; P &lt; .001) and 2 days (1.57 vs 2.19; P &lt; .001) after the previous appointment. Only 26.5% of the patients used pain medication immediately following and 1 day after the last appointment. Providers underestimated the amount of medication used.
Conclusion: Orthodontists underestimated the degree to which orthodontic treatment caused pain for their patients and their patients' use of pain medication.
Hematoma enlargement in spontaneous intracerebral hemorrhage
Authors: Fujii Yukihiko , Tanaka Ryuichi , Takeuchi Shigekazu , Koike Tetsuo , Minakawa Takashi , Sasaki Osamu 
Published: May 2009

✓ In order to evaluate the incidence and risk factors of hematoma enlargement in spontaneous intracerebral hemorrhage (ICH), 419 cases of ICH were reviewed. The first computerized tomography (CT) scan was performed within 24 hours of onset and the second within 24 hours of admission; a blood sample was taken for laboratory examination within 1 hour of admission. In 60 patients (14.3%) the second CT scan showed an enlarged hematoma. The incidence of enlargement significantly decreased with time (p < 0.05) and significantly increased with the severity of liver dysfunction and the volume of the hematoma on the first CT scan. Patients with an irregularly shaped hematoma had a higher risk of hematoma growth than those with a round hematoma. In addition, patients with hematoma enlargement were more likely to have coagulation abnormalities (low platelet counts and low levels of fibrinogen, α2-antiplasmin activity and platelet aggregation). Moreover, hematoma growth was associated with a poor clinical outcome.
It is concluded that patients admitted to a hospital within 6 hours of onset of ICH, especially those admitted within 2 hours, and patients with liver dysfunction or irregularly shaped large hematomas should be closely observed for at least 6 hours after onset in preparation for emergency surgery, since the risk of hematoma growth in these circumstances is high.
The natural history of familial cavernous malformations: results of an ongoing study
Authors: Zabramski Joseph M. , Wascher Thomas M. , Spetzler Robert F. , Johnson Blake , Golfinos John , Drayer Burton P. , Brown Ben , Rigamonti Daniel , Brown Geraldine 
Published: May 2009

✓ Cavernous malformations are congenital abnormalities of the cerebral vessels that affect 0.5% to 0.7% of the population. They occur in two forms: a sporadic form characterized by isolated lesions, and a familial form characterized by multiple lesions with an autosomal dominant mode of inheritance. The management of patients with cavernous malformations, particularly those with the familial form of the disease, remains a challenge because little is known regarding the natural history.
The authors report the results of an ongoing study in which six families afflicted by familial cavernous malformations have been prospectively followed with serial interviews, physical examinations, and magnetic resonance (MR) imaging at 6- to 12-month intervals. A total of 59 members of these six families were screened for protocol enrollment; 31 (53%) had MR evidence of familial cavernous malformations. Nineteen (61%) of these 31 patients were symptomatic, with seizures in 12 (39%), recurrent headaches in 16 (52%), focal sensory/motor deficits in three (10%), and visual field deficits in two (6%). Twenty-one of these 31 patients underwent at least two serial clinical and MR imaging examinations. A total of 128 individual cavernous malformations (mean 6.5 ± 3.8 lesions/patient) were identified and followed radiographically. During a mean follow-up period of 2.2 years (range 1 to 5.5 years), serial MR images demonstrated 17 new lesions in six (29%) of the 21 patients; 13 lesions (10%) showed changes in signal characteristics, and five lesions (3.9%) changed significantly in size. The incidence of symptomatic hemorrhage was 1.1% per lesion per year.
The results of this study demonstrate that the familial form of cavernous malformations is a dynamic disease; serial MR images revealed changes in the number, size, and imaging characteristics of lesions consistent with acute or resolving hemorrhage. It is believed that the de novo development of new lesions in this disease has not been previously reported. These findings suggest that patients with familial cavernous malformations require careful follow-up monitoring, and that significant changes in neurological symptoms warrant repeat MR imaging. Surgery should be considered only for lesions that produce repetitive or progressive symptoms. Prophylactic resection of asymptomatic lesions does not appear to be indicated.
Surgical management of unruptured intracranial aneurysms
Authors: Solomon Robert A. , Fink Matthew E. , Pile-Spellman John 
Published: May 2009

✓ The surgical management of patients with unruptured intracranial aneurysms continues to be controversial. The criteria for withholding treatment or choosing between endovascular embolization and conventional microsurgery are not well delineated. The present study analyzes the morbidity and mortality that can be expected with modern surgical management of unruptured aneurysms, and therefore serves as a point of reference for clinical decision-making in this group of patients.
A total of 202 consecutive operations for attempted clipping of unruptured intracranial aneurysms are reported. Subarachnoid hemorrhage from another aneurysm was the most common presentation (55 cases). Thirty-seven patients presented with headache, 36 with mass effect from the aneurysm, and 19 with embolic events; 11 aneurysms were associated with an arteriovenous malformation, 10 caused seizures, and 34 were incidental findings. Excellent or good outcome was achieved in 100% of patients with aneurysms less than 10 mm in diameter, 95% with aneurysms 11 to 25 mm, and 79% with aneurysms greater than 25 mm.
Except for giant basilar aneurysms, size (and not location) of the aneurysm was the key predictor of risk for surgical morbidity. These data may be useful when discussing with patients the risk:benefit ratio of choosing between conservative management, endovascular embolization, and microsurgical clipping.
Optimum degree of hemodilution for brain protection in a canine model of focal cerebral ischemia
Authors: Lee Sun Ho , Heros Roberto C. , Mullan John C. , Korosue Kazuyoshi 
Published: May 2009

✓ The ability of hemodilution to lower blood viscosity and increase cerebral blood flow has been proven experimentally; however, the optimum hematocrit for maximum oxygen delivery to ischemic brain tissue is not known, and a study was designed to determine this. Fifty dogs were selected for inclusion in the study using criteria based on changes in somatosensory evoked potentials at the time of arterial occlusion, which were found in a previous study to predict the development of a moderate infarction of relatively constant size. Infarctions were induced by permanent occlusion of the left middle cerebral artery and the azygous anterior cerebral artery. The animals selected for inclusion were divided into five groups of 10 dogs each: 1) a control group; 2) a group with 25% hematocrit; 3) a group with 30% hematocrit; 4) a group with 35% hematocrit; and 5) a group with 40% hematocrit. Isovolemic hemodilution was accomplished 1 hour after occlusion of vessels using dextran infusion and blood withdrawal. The animals were sacrificed after 6 days and infarction volume was determined from fluorescein-stained sections. Statistical analysis was performed using Student's t-test and one-way analysis of variance.
Mean infarction volume for each group, expressed as a percentage of total hemispheric volume ± 1 standard error of the mean, was 28.3% ± 2.8% for the control group, 33.6% ± 3.4% for the 25% hematocrit group, 17.1% ± 2.2% for the 30% hematocrit group, 29.2% ± 4.3% for the 35% hematocrit group, and 29.9% ± 2.1% for the 40% hematocrit group. The 30% hematocrit group showed the smallest average infarction size and this size differed significantly (p = 0.02) from the average infarction size in the control animals. These results show that, in this model of focal ischemia, a hematocrit of approximately 30% is optimum for protecting the brain.
Intrastriatal implantation of interleukin-1
Authors: Wang Jin , Bankiewicz Krzysztof S. , Plunkett Robert J. , Oldfield Edward H. 
Published: May 2009

✓ Intrastriatal implantation with dopaminergic or nondopaminergic tissue can elicit behavioral recovery in parkinsonian animals. Because in these animals, especially in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned monkeys, there are still considerable numbers of dopaminergic neurons left in the mesencephalon, implantation-induced trophic effects on host residual dopaminergic neurons have been suggested as a mechanism underlying the behavioral recovery. Gliosis around the graft is a universal finding in any implantation procedure and is probably mediated by interleukin-1 (IL-1); in addition, activated astrocytes secrete several neurotrophic factors in vitro. Therefore, the authors postulated that trophic effects from IL-1-induced gliosis may be a “final common pathway” for recovery in parkinsonian animals after implantation.
Hemiparkinsonism was induced in rats by injection of 6-hydroxydopamine either directly into the substantia nigra or into the median forebrain bundle. The substantia nigra-lesioned rats showed complete depletion of dopaminergic neurons in the substantia nigra but sparing of those in the ventral tegmental area, whereas the median forebrain bundle-lesioned animals had depletion of dopaminergic cells in the substantia nigra and the ventral tegmental area. Polymer pellets containing either slow-released IL-1 alpha and beta or placebo pellets were implanted in the caudate nucleus on the lesioned side in both groups. The rats' rotational response to amphetamine was tested weekly for 8 weeks. Selective substantia nigra-lesioned rats with implantation of IL-1 pellets had a 45% reduction in amphetamine-induced rotation, whereas placebo-implanted substantia nigra-lesioned rats had a 14% reduction in rotation. In the median forebrain bundle-lesioned group, neither IL-1 nor placebo implantation elicited any effect on turning. Immunohistochemical staining for glial fibrillary acidic protein was markedly increased surrounding the IL-1 pellets compared to the placebo pellets. In the selective substantia nigra-lesioned rats with IL-1 pellets implanted in the caudate nucleus, a considerable number of tyrosine hydroxylase immunoreactive (TH-IR) fibers were observed in the medial and middle portions of the caudate nucleus. Fewer TH-IR fibers were seen in the rats with placebo-bearing pellets.
These results suggest that neurotrophic activities mediated by IL-1 and reactive astrocytes might be a common path through which tissue trauma and some tissue transplants exert their beneficial effects in parkinsonian animals. Furthermore, most of the sprouted dopaminergic fibers induced by IL-1 in the caudate nucleus come from dopaminergic neurons in the ventral tegmental area.
Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice
Authors: Laske Douglas W. , Ilercil Orhan , Akbasak Aytac , Youle Richard J. , Oldfield Edward H. 
Published: May 2009

✓ Targeted protein toxins are a new class of reagents with the potential for great tumor selectivity and cytotoxic potency. Two such compounds were studied: 1) Tf-CRM107, a conjugate of human transferrin (Tf) and diphtheria toxin with a point mutation (CRM107); and 2) 454A12-rRA, a conjugate of a monoclonal antibody (454A12) to the human Tf receptor and recombinant ricin A chain (rRA). Both compounds are potent and specific in killing human glioblastoma cell linesin vitro. The authors investigated the activity of these reagents administered intratumorally against solid U251 MG human gliomasin vivo.Nude mice with established U251 MG flank tumors (0.5 to 1.0 cm in diameter) were randomly assigned to be treated with 100-µl intratumoral injections of Tf-CRM107 (10 µg) or 454A12-rRA (10 µg), equimolar doses of CRM107 (4.3 µg), 454A12 antibody (7.5 µg), or rRA (1.5 µg), or phosphate-buffered saline (PBS) every 2 days for a total of four doses. Tumor volume and animal weight were assessed by a blinded observer before each treatment and biweekly for 30 days after initiating therapy. With Tf-CRM107 administration, tumor regression of greater than 95% occurred by Day 14 (p < 0.01) and tumors did not recur by Day 30. Treatment with 454A12-rRA caused a 30% decrease in tumor volume by Day 14 (p < 0.01). Treatment with equimolar doses of the unconjugated targeted protein toxin components CRM107, 454A12, or rRA caused significant U251 MG tumor growth inhibition, but the effects were less potent than the antitumor effects of the conjugates.This study also characterized the dose-response effect of Tf-CRM107 on tumor growth and tumor weight on Day 30. Nude mice with established U251 MG flank tumors (0.5 to 1.0 cm in diameter) were treated with 100-µl intratumoral injections of 10, 1.0, or 0.1 µg of Tf-CRM107 or PBS every 2 days for a total of four doses. All three doses of Tf-CRM107 significantly inhibited tumor growth by Day 14 (p < 0.01) and at Day 30 (p < 0.05), with a significant dose-response relationship.This study demonstratedin vivoefficacy of the targeted toxins Tf-CRM107 and 454A12-rRA against a human glioma. With intratumoral administration, the effect of Tf-CRM107 was tumor-specific and in some animals curative. Regional therapy with these potent tumor-specific agents using direct intratumoral infusion should limit systemic toxicity and may be efficacious against brain tumors.
Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo
Authors: Matsuda Yasuhiro , Kawamoto Keiichi , Kiya Katsuzo , Kurisu Kaoru , Sugiyama Kazuhiko , Uozumi Tohru 
Published: May 2009

✓ The presence of the progesterone receptor (PR) in meningioma tissue has been confirmed by previous investigations. Studies have shown that the antiprogesterone drug, mifepristone, is a potent agent that inhibits the growth of cultured meningioma cells and reduces the size of meningiomas in experimental animal models and humans. However, these studies have not fully examined the relationship between the antitumor effects of an antiprogesterone agent and the expression of the PR.The present study examined the antitumor effects of mifepristone and a new potent antiprogesterone agent, onapristone; a correlation between the antitumor effects of these antiprogesterones and the presence of PR's in meningiomasin vitroandin vivowas also investigated. Meningioma tissue surgically removed from 13 patients was used in this study. In thein vitroarm of the study, mifepristone and onapristone exhibited cytostatic and cytocidal effects against cultured meningioma cells, regardless of the presence or absence of PR's; however, three PR-negative meningiomas showed no response to any dose of mifepristone and/or onapristone. In thein vivoarm, meningioma cells, embedded in a collagen gel, were implanted into the renal capsules of nude mice. Antiprogesterone treatment resulted in a marked reduction of the tumor volume regardless of the presence or absence of PR's. No histological changes in the meningioma cells suggestive of necrosis or apoptosis were detected in any of the mice treated with antiprogesterones. These findings suggest that mifepristone and onapristone have an antitumor effect against meningioma cells via the PR's and/or another receptor, such as the glucocorticoid receptor.